RxDoctor Payments Data

David Schomas, MD

Radiation Oncology · Kansas City, MONPI 1811974199

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.7% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 13.1% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for radiation oncology clinicians in MO, where the typical reported total is $706.

$727in general payments, 2019–2025

Across 33 payments — averaging $22.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novocure Inc.$95
  • Sanofi$73
  • Geron Corporation$59
  • Acrotech Biopharma Inc.$53
  • Incyte Corporation$40
  • Eisai Inc.$39
  • plus $367 from 17 others

What the payments were for

  • Food & beverage$70397%
  • Education$243%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$727 in reported general payments places this provider in the 50th percentile of 123 radiation oncology providers in Missouri.

See all radiation oncology providers in Missouri →

Medicare billing

Part B allowed, 2024
$384,898
Medicare patients
409
Services billed
4,520

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen60$1,726
Dexamethasone42$681
Oxycodone Hcl50$625
Lidocaine Hcl ViscousLidocaine Hcl15$446
Tamsulosin Hcl15$187
Ondansetron OdtOndansetron15$172
Prochlorperazine Maleate14$158
Memantine Hcl14$86

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Kansas City

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →